Chanez Narimene Kebache, MBA
About Chanez Narimene Kebache, MBA
Chanez Narimene Kebache, MBA, serves as the Director of Global Drug Safety & Pharmacovigilance at Canopy Growth Corporation. With a background in microbiology and extensive experience in pharmacovigilance, she has held various leadership roles in the pharmaceutical industry since 2009.
Current Role at Canopy Growth Corporation
Chanez Narimene Kebache serves as the Director of Global Drug Safety & Pharmacovigilance at Canopy Growth Corporation. She has held this position since 2019, contributing her expertise in drug safety and pharmacovigilance within the cannabis industry. Her role involves overseeing safety assessments and ensuring compliance with regulatory standards related to drug safety.
Previous Experience in Pharmacovigilance
Prior to her current role, Kebache worked at Mallinckrodt Pharmaceuticals as the Director of Pharmacovigilance & Drug Safety Canada from 2012 to 2019. She also held positions at Covidien as a Drug Safety Surveillance Specialist and at Axcan Pharma as a Pharmacovigilance Specialist. Her extensive experience in these roles has equipped her with a solid foundation in drug safety practices.
Education and Academic Background
Kebache earned her Master of Business Administration (M.B.A.) from HEC Montréal, where she studied from 2014 to 2016. Prior to that, she completed her Bachelor’s degree in Microbiology and Immunology at Université de Montréal from 2001 to 2004. Her academic background supports her professional expertise in pharmacovigilance and drug safety.
Involvement with DIA
Chanez Narimene Kebache was a Program Committee member for the Drug Information Association (DIA) during the 10th Annual Canadian Meeting from 2011 to 2015. This involvement reflects her commitment to the advancement of drug safety practices and her engagement with the professional community in pharmacovigilance.